Concepedia
Statistics
Publications
19
Citations
1.6K
H-Index
18
Active since
1989
Affiliations
Nerviano Medical Sciences(Current)
Novartis (Switzerland)
University of Cologne
University of Freiburg
Utrecht University
Gemma Texidó is an author at Nerviano Medical Sciences specializing in cell biology, medicine, and cell signaling.
Top concepts
MedicineCell BiologyCell SignalingImmunologyImmunogeneticsSignal TransductionCell DeathAutoimmunityTumor BiologyCell Development
Publications per year
1989–2016
Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 308 citations · Full text
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini et al. · Molecular Cancer Therapeutics · 2007 · 240 citations
Histone H3, Potent Inhibitor, Cancer Biology +16
The Level of C/EBP Protein Is Critical for Cell Migration during Drosophila Oogenesis and Is Tightly Controlled by Regulated Degradation
Pernille Rørth, Kornélia Szabó, Gemma Texidó · Molecular Cell · 2000 · 163 citations · Full text
Developmental Biology, Cell Regulation, Regulated Degradation +9
The Molecular Mechanism of B Cell Activation by <i>toll</i>-like Receptor Protein RP-105
Vivien W. Chan, Ingrid Mecklenbräuker, I-hsin Su et al. · The Journal of Experimental Medicine · 1998 · 97 citations · Full text
Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development.
Aribert Stief, Gemma Texidó, Gilles Sansig et al. · The Journal of Immunology · 1994 · 94 citations · Full text
1–5 of 19